• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Xenia Hotels & Resorts Announces the Appointment of Terrence Moorehead to its Board of Directors

    5/26/21 6:30:00 AM ET
    $XHR
    $NATR
    Hotels/Resorts
    Consumer Discretionary
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $XHR alert in real time by email

    ORLANDO, Fla., May 26, 2021 /PRNewswire/ -- Xenia Hotels & Resorts, Inc. (NYSE:XHR) ("Xenia" or the "Company") today announced the appointment of Mr. Terrence Moorehead to its Board of Directors, effective May 25, 2021.  Mr. Moorehead was also appointed as a member of the Audit Committee effective May 25, 2021. With the appointment, the Company's Board of Directors increased to nine members, eight of whom are independent, including Mr. Moorehead. 

    "On behalf of the Board of Directors and the management team, we are pleased to welcome Terrence to our Board," commented Marcel Verbaas, Chairman and Chief Executive Officer of Xenia.  "Terrence brings a fresh and diverse perspective to the Board, and we look forward to his contributions that will further enhance our leadership. His expertise in high-end consumer products and behaviors as well as his experience in and focus on health and wellness are valuable attributes that are directly relevant to the upper upscale and luxury lodging segments. Additionally, his strategic insights that have been honed by executive leadership roles throughout the world will be of significant value."

    Mr. Moorehead currently serves as President, Chief Executive Officer, and a director on the board of Nature's Sunshine Products, Inc (NASDAQ:NATR) ("Nature's Sunshine"), a leading natural health and wellness company.  Prior to joining Nature's Sunshine in 2018, Mr. Moorehead was Chief Executive Officer at Carlisle Etcetera LLC from 2015 through 2018, and at Dana Beauty, Inc. from 2013 to 2015.  From 1991 to 2013 he served in various capacities at Avon Products, Inc., including, among other positions, as VP, Strategy and Digital, North America, President and Chairman of Avon Japan, President of Avon Canada, and General Manager of Avon Italy. 

    Mr. Moorehead received his Master of Business Administration from Columbia University and a Bachelor of Arts in Economics from Boston College.

    "I am excited to be joining Xenia's Board of Directors and to have the opportunity to work with such an outstanding team of professionals. The Company's high-quality properties, differentiated portfolio, and top-notch management team are a powerful combination and I look forward to working with the team to deliver increased shareholder value," commented Mr. Moorehead.

    About Xenia Hotels & Resorts, Inc.

    Xenia Hotels & Resorts, Inc. is a self-advised and self-administered REIT that invests in uniquely positioned luxury and upper upscale hotels and resorts with a focus on the top 25 U.S. lodging markets as well as key leisure destinations in the United States. The Company owns 35 hotels and resorts comprising 10,011 rooms across 15 states. Xenia's hotels are in the luxury and upper upscale segments, and are operated and/or licensed by industry leaders such as Marriott, Hyatt, Kimpton, Fairmont, Loews, Hilton, and The Kessler Collection. For more information on Xenia's business, refer to the Company website at www.xeniareit.com.

    This press release contains statements as to the Company's beliefs and expectations of the outcome of future events that are forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995 and within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. You can identify these statements by the fact that they do not relate strictly to historical or current facts. These forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from the statements made. These risks and uncertainties include, but are not limited to, the effects of the COVID-19 pandemic, including on the demand for travel, transient and group business (including, but not limited to, government-imposed travel or meeting restrictions), and levels of consumer confidence in the safety of travel as a result of the pandemic; the length of the COVID-19 pandemic and severity of such pandemic in the United States; the pace of economic recovery and the recovering of consumer confidence following the COVID-19 pandemic; our ability to implement cost-containment strategies; the adverse effects of the COVID-19 pandemic on our business or the market price of our common stock; and our ability to service, restructure or refinance our debt; our ability to be in compliance with our debt covenants; our ability to access capital on acceptable terms or at all and uncertainty in both the debt and equity capital markets; and the outcome of legal proceedings or other disputes. Other factors that could cause results to differ are described in the filings made from time to time by the Company with the U.S. Securities and Exchange Commission and include the risk factors and other risks and uncertainties described in the Company's Annual Report on Form 10-K for the year ended December 31, 2020, its Quarterly Report on Form 10-Q for the quarter ended March 31, 2021 and its Current Reports on Form 8-K. Except as required by law, the Company does not undertake, and hereby disclaims, any obligation to release publicly any revisions to forward-looking statements made by it to reflect events or circumstances occurring after the date hereof or the occurrence of unanticipated events.

    Cision View original content:http://www.prnewswire.com/news-releases/xenia-hotels--resorts-announces-the-appointment-of-terrence-moorehead-to-its-board-of-directors-301299385.html

    SOURCE Xenia Hotels & Resorts, Inc.

    Get the next $XHR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $XHR
    $NATR

    CompanyDatePrice TargetRatingAnalyst
    Nature's Sunshine Products Inc.
    $NATR
    5/7/2025$19.00Buy
    DA Davidson
    Xenia Hotels & Resorts Inc.
    $XHR
    4/9/2025$10.00Buy → Hold
    Jefferies
    Xenia Hotels & Resorts Inc.
    $XHR
    9/13/2024$16.00 → $15.00Equal Weight → Overweight
    Wells Fargo
    Nature's Sunshine Products Inc.
    $NATR
    9/13/2024$18.00Buy
    Canaccord Genuity
    Xenia Hotels & Resorts Inc.
    $XHR
    3/4/2024$16.00 → $17.00Buy → Neutral
    B. Riley Securities
    Xenia Hotels & Resorts Inc.
    $XHR
    2/29/2024$14.00 → $18.00Hold → Buy
    Jefferies
    Xenia Hotels & Resorts Inc.
    $XHR
    1/10/2024Peer Perform
    Wolfe Research
    Xenia Hotels & Resorts Inc.
    $XHR
    3/30/2023$18.00 → $13.00Overweight → Equal Weight
    Wells Fargo
    More analyst ratings

    $XHR
    $NATR
    SEC Filings

    View All

    SEC Form S-8 filed by Nature's Sunshine Products Inc.

    S-8 - NATURES SUNSHINE PRODUCTS INC (0000275053) (Filer)

    5/15/26 4:52:47 PM ET
    $NATR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 8-K filed by Xenia Hotels & Resorts Inc.

    8-K - Xenia Hotels & Resorts, Inc. (0001616000) (Filer)

    5/14/26 4:19:39 PM ET
    $XHR
    Hotels/Resorts
    Consumer Discretionary

    Nature's Sunshine Products Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - NATURES SUNSHINE PRODUCTS INC (0000275053) (Filer)

    5/11/26 8:46:55 AM ET
    $NATR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $XHR
    $NATR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP & President, Asia Norman Daniel C sold $200,476 worth of shares (9,713 units at $20.64), decreasing direct ownership by 17% to 47,276 units (SEC Form 4)

    4 - NATURES SUNSHINE PRODUCTS INC (0000275053) (Issuer)

    6/3/26 6:44:18 PM ET
    $NATR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    EVP, General Counsel Brower Nathan G sold $262,408 worth of shares (12,015 units at $21.84), decreasing direct ownership by 22% to 43,438 units (SEC Form 4)

    4 - NATURES SUNSHINE PRODUCTS INC (0000275053) (Issuer)

    5/22/26 11:59:55 AM ET
    $NATR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Fasching Steven J. was granted 4,500 shares, increasing direct ownership by 41% to 15,369 units (SEC Form 4)

    4 - NATURES SUNSHINE PRODUCTS INC (0000275053) (Issuer)

    5/20/26 12:17:48 PM ET
    $NATR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $XHR
    $NATR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    DA Davidson resumed coverage on Nature's Sunshine with a new price target

    DA Davidson resumed coverage of Nature's Sunshine with a rating of Buy and set a new price target of $19.00

    5/7/25 8:37:48 AM ET
    $NATR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Xenia Hotels downgraded by Jefferies with a new price target

    Jefferies downgraded Xenia Hotels from Buy to Hold and set a new price target of $10.00

    4/9/25 8:06:14 AM ET
    $XHR
    Hotels/Resorts
    Consumer Discretionary

    Xenia Hotels upgraded by Wells Fargo with a new price target

    Wells Fargo upgraded Xenia Hotels from Equal Weight to Overweight and set a new price target of $15.00 from $16.00 previously

    9/13/24 7:48:19 AM ET
    $XHR
    Hotels/Resorts
    Consumer Discretionary

    $XHR
    $NATR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Xenia Hotels & Resorts Declares Dividend for Second Quarter 2026

    ORLANDO, Fla., May 15, 2026 /PRNewswire/ -- Xenia Hotels & Resorts, Inc. (NYSE:XHR) ("Xenia" or the "Company") today announced that its Board of Directors authorized a cash dividend of $0.14 per share of the Company's common stock for the second quarter 2026. The dividend will be paid on July 15, 2026 to all holders of record of the Company's common stock as of the close of business on June 30, 2026.About Xenia Hotels & Resorts, Inc.Xenia Hotels & Resorts, Inc. is a self-advised and self-administered REIT that invests in uniquely positioned luxury and upper upscale hotels and resorts with a focus on the top 25 lodging markets as well as key leisure destinations in the United States. The Comp

    5/15/26 6:30:00 AM ET
    $XHR
    Hotels/Resorts
    Consumer Discretionary

    Nature's Sunshine Reports Strong First Quarter 2026 Results

    Net Sales up 9% to $122.9 million, GAAP EPS up 16% to $0.29Adjusted EBITDA up 33% to $14.6 million LEHI, Utah, May 07, 2026 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ:NATR) ("Nature's Sunshine" and/or the "Company"), a global leader in manufacturing and marketing high-quality herbal and nutritional supplements, reported financial results for the first quarter ended March 31, 2026. First Quarter 2026 Financial Summary vs. Same Year-Ago Quarter Net sales were up 9% to $122.9 million compared to $113.2 million (up 7% in constant currency).Gross profit margin increased 116 basis points to 73.2% compared to 72.1%.GAAP net income attributable to common shareholders was $5.1

    5/7/26 4:05:00 PM ET
    $NATR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Xenia Hotels & Resorts Reports First Quarter 2026 Results

    ORLANDO, Fla., May 1, 2026 /PRNewswire/ -- Xenia Hotels & Resorts, Inc. (NYSE:XHR) ("Xenia" or the "Company") today announced results for the quarter ended March 31, 2026.First Quarter 2026 HighlightsNet Income: Net income attributable to common stockholders was $19.8 million, or $0.21 per shareAdjusted EBITDAre: $81.4 million, increased 11.6% compared to the first quarter of 2025Adjusted FFO per Diluted Share: $0.63, increased 23.5% compared to the first quarter of 2025Same-Property Occupancy: 71.4%, increased 180 basis points compared to the first quarter of 2025Same-Property ADR: $288.62, increased 4.8% compared to the first quarter of 2025Same-Property RevPAR: $205.93, increased 7.4% com

    5/1/26 6:30:00 AM ET
    $XHR
    Hotels/Resorts
    Consumer Discretionary

    $XHR
    $NATR
    Financials

    Live finance-specific insights

    View All

    Xenia Hotels & Resorts Declares Dividend for Second Quarter 2026

    ORLANDO, Fla., May 15, 2026 /PRNewswire/ -- Xenia Hotels & Resorts, Inc. (NYSE:XHR) ("Xenia" or the "Company") today announced that its Board of Directors authorized a cash dividend of $0.14 per share of the Company's common stock for the second quarter 2026. The dividend will be paid on July 15, 2026 to all holders of record of the Company's common stock as of the close of business on June 30, 2026.About Xenia Hotels & Resorts, Inc.Xenia Hotels & Resorts, Inc. is a self-advised and self-administered REIT that invests in uniquely positioned luxury and upper upscale hotels and resorts with a focus on the top 25 lodging markets as well as key leisure destinations in the United States. The Comp

    5/15/26 6:30:00 AM ET
    $XHR
    Hotels/Resorts
    Consumer Discretionary

    Nature's Sunshine Reports Strong First Quarter 2026 Results

    Net Sales up 9% to $122.9 million, GAAP EPS up 16% to $0.29Adjusted EBITDA up 33% to $14.6 million LEHI, Utah, May 07, 2026 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ:NATR) ("Nature's Sunshine" and/or the "Company"), a global leader in manufacturing and marketing high-quality herbal and nutritional supplements, reported financial results for the first quarter ended March 31, 2026. First Quarter 2026 Financial Summary vs. Same Year-Ago Quarter Net sales were up 9% to $122.9 million compared to $113.2 million (up 7% in constant currency).Gross profit margin increased 116 basis points to 73.2% compared to 72.1%.GAAP net income attributable to common shareholders was $5.1

    5/7/26 4:05:00 PM ET
    $NATR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Xenia Hotels & Resorts Reports First Quarter 2026 Results

    ORLANDO, Fla., May 1, 2026 /PRNewswire/ -- Xenia Hotels & Resorts, Inc. (NYSE:XHR) ("Xenia" or the "Company") today announced results for the quarter ended March 31, 2026.First Quarter 2026 HighlightsNet Income: Net income attributable to common stockholders was $19.8 million, or $0.21 per shareAdjusted EBITDAre: $81.4 million, increased 11.6% compared to the first quarter of 2025Adjusted FFO per Diluted Share: $0.63, increased 23.5% compared to the first quarter of 2025Same-Property Occupancy: 71.4%, increased 180 basis points compared to the first quarter of 2025Same-Property ADR: $288.62, increased 4.8% compared to the first quarter of 2025Same-Property RevPAR: $205.93, increased 7.4% com

    5/1/26 6:30:00 AM ET
    $XHR
    Hotels/Resorts
    Consumer Discretionary

    $XHR
    $NATR
    Leadership Updates

    Live Leadership Updates

    View All

    Nature's Sunshine Appoints John Hnanicek as Chief Technology Officer

    LEHI, Utah, April 30, 2026 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ:NATR) ("Nature's Sunshine") (the "Company"), a global leader in manufacturing and marketing high-quality herbal and nutritional supplements, today announced that John Hnanicek has been appointed Chief Technology Officer, effective May 4, 2026. Mr. Hnanicek brings decades of senior leadership experience in technology, digital innovation, and e-commerce transformation across leading consumer, retail, and direct-to-consumer organizations. He most recently served as Chief Digital Innovation Officer at Melaleuca, where he led enterprise-wide digital initiatives, technology modernization, and customer innova

    4/30/26 8:00:00 AM ET
    $NATR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Nature's Sunshine Appoints Erich Fritz as Executive Vice President of Global Supply Chain

    LEHI, Utah, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ:NATR) ("Nature's Sunshine") (the "Company"), a leading manufacturer of high-quality herbal and nutritional supplements, today announced that Erich Fritz has been named Executive Vice President, Global Supply Chain, effective December 8, 2025. Mr. Fritz will report directly to Ken Romanzi, the Company's Chief Executive Officer. Mr. Fritz brings over 40 years of executive experience in operations, supply chain, and business development, with a proven track record of driving growth, operational efficiency, and innovation at leading consumer goods companies. His leadership spans Fortune 500 organizations an

    12/4/25 10:00:00 AM ET
    $NATR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Nature's Sunshine Appoints Kenneth Romanzi as CEO

    Mr. Romanzi Brings Extensive Leadership and Operational Experience at Prominent, Large-Scale Consumer Packaged Goods Companies and Proven Track Record of Driving Growth and Value Creation LEHI, Utah, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ:NATR) ("Nature's Sunshine") (the "Company"), a leading manufacturer of high-quality herbal and nutritional supplements, today announced that its Board of Directors has appointed Kenneth Romanzi to succeed Terrence Moorehead as Chief Executive Officer. Mr. Romanzi will assume the role and become a member of the Nature's Sunshine Board of Directors on October 29, 2025. Mr. Romanzi is an experienced CEO and operator with

    10/15/25 9:00:00 AM ET
    $NATR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $XHR
    $NATR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Xenia Hotels & Resorts Inc. (Amendment)

    SC 13G/A - Xenia Hotels & Resorts, Inc. (0001616000) (Subject)

    2/13/24 5:17:34 PM ET
    $XHR
    Hotels/Resorts
    Consumer Discretionary

    SEC Form SC 13G/A filed by Nature's Sunshine Products Inc. (Amendment)

    SC 13G/A - NATURES SUNSHINE PRODUCTS INC (0000275053) (Subject)

    2/12/24 10:37:49 AM ET
    $NATR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G/A filed by Xenia Hotels & Resorts Inc. (Amendment)

    SC 13G/A - Xenia Hotels & Resorts, Inc. (0001616000) (Subject)

    2/9/24 8:40:49 AM ET
    $XHR
    Hotels/Resorts
    Consumer Discretionary